Non Melanoma Skin Cancer Pathogenesis Overview

Overview

Journal Biomedicines

Specialty Biomedical Engineering

Date 2018 Jan 6

PMID 29301290

Citations 93

Authors

Dario Didona

Giovanni Paolino

Ugo Bottoni

Carmen Cantisani

Affiliations

Soon will be listed here.

Abstract

(1) Background: Non-melanoma skin cancer is the most frequently diagnosed cancer in humans. The process of skin carcinogenesis is still not fully understood. However, several studies have been conducted to better explain the mechanisms that lead to malignancy; (2) Methods: We reviewed the more recent literature about the pathogenesis of non-melanoma skin cancer focusing on basal cell carcinomas, squamous cell carcinoma and actinic keratosis; (3) Results: Several papers reported genetic and molecular alterations leading to non-melanoma skin cancer. Plenty of risk factors are involved in non-melanoma skin cancer pathogenesis, including genetic and molecular alterations, immunosuppression, and ultraviolet radiation; (4) Conclusion: Although skin carcinogenesis is still not fully understood, several papers demonstrated that genetic and molecular alterations are involved in this process. In addition, plenty of non-melanoma skin cancer risk factors are now known, allowing for an effective prevention of non-melanoma skin cancer development. Compared to other papers on the same topic, our review focused on molecular and genetic factors and analyzed in detail several factors involved in non-melanoma skin cancer.

Citing Articles

Bioadhesive Nanoparticles in Topical Drug Delivery: Advances, Applications, and Potential for Skin Disorder Treatments.

Almuqbil R, Aldhubiab B Pharmaceutics. 2025; 17(2).

PMID: 40006596 PMC: 11860006. DOI: 10.3390/pharmaceutics17020229.

Illuminating the Connection: Cutaneous Vitamin D Synthesis and Its Role in Skin Cancer Prevention.

Ucar N, Holick M Nutrients. 2025; 17(3).

PMID: 39940244 PMC: 11821240. DOI: 10.3390/nu17030386.

Analysis of IL10 gene promoter haplotypes and changes in mRNA expression and soluble levels in patients with basal cell carcinoma.

Jimenez-Del Rio L, Zambrano-Roman M, Valdez-Salazar F, Valle Y, Munoz-Valle J, Padilla-Gutierrez J Arch Dermatol Res. 2025; 317(1):274.

PMID: 39825930 DOI: 10.1007/s00403-025-03806-x.

Enhanced Expression of N-Cadherin, but Not of E-Cadherin, in Cutaneous Squamous Cell Carcinoma in Comparison to Basal Cell Carcinoma.

Pogorzelska-Dyrbus J, Nowicka-Suszko D, Piotrowska A, Wozniak Z, Dziegiel P, Szepietowski J Cancers (Basel). 2025; 16(24.

PMID: 39766148 PMC: 11674879. DOI: 10.3390/cancers16244247.

Effects of Resveratrol on Nonmelanoma Skin Cancer (NMSC): A Comprehensive Review.

Zamanian M, Shahbazi T, Kazmi S, Hussien B, Sharma A, Qasim M Food Sci Nutr. 2024; 12(11):8825-8845.

PMID: 39620024 PMC: 11606877. DOI: 10.1002/fsn3.4555.

References

Edovitsky E, Lerner I, Zcharia E, Peretz T, Vlodavsky I, Elkin M . Role of endothelial heparanase in delayed-type hypersensitivity. Blood. 2005; 107(9):3609-16. PMC: 1444937. DOI: 10.1182/blood-2005-08-3301. View

Glover M, Bodmer J, Bodmer W, Kennedy L, Brown J, Navarrete C . HLA antigen frequencies in renal transplant recipients and non-immunosuppressed patients with non-melanoma skin cancer. Eur J Cancer. 1993; 29A(4):520-4. DOI: 10.1016/s0959-8049(05)80143-1. View

Ullrich S . Mechanisms underlying UV-induced immune suppression. Mutat Res. 2005; 571(1-2):185-205. DOI: 10.1016/j.mrfmmm.2004.06.059. View

Saldanha G, Fletcher A, Slater D . Basal cell carcinoma: a dermatopathological and molecular biological update. Br J Dermatol. 2003; 148(2):195-202. DOI: 10.1046/j.1365-2133.2003.05151.x. View

Apalla Z, Nashan D, Weller R, Castellsague X . Skin Cancer: Epidemiology, Disease Burden, Pathophysiology, Diagnosis, and Therapeutic Approaches. Dermatol Ther (Heidelb). 2017; 7(Suppl 1):5-19. PMC: 5289116. DOI: 10.1007/s13555-016-0165-y. View

Santos M, Silva C, Rocha A, Nogueira C, Castro-Pocas F, Araujo A . Predictive clinical model of tumor response after chemoradiation in rectal cancer. Oncotarget. 2017; 8(35):58133-58151. PMC: 5601639. DOI: 10.18632/oncotarget.19651. View

Urosevic M, Dummer R . Immunotherapy for nonmelanoma skin cancer: does it have a future?. Cancer. 2002; 94(2):477-85. DOI: 10.1002/cncr.10178. View

Li Q, Yang X, Xu F, Sharma C, Wang H, Knoblich K . Tetraspanin CD151 plays a key role in skin squamous cell carcinoma. Oncogene. 2012; 32(14):1772-83. PMC: 3482293. DOI: 10.1038/onc.2012.205. View

Lichter M, Karagas M, Mott L, Spencer S, Stukel T, Greenberg E . Therapeutic ionizing radiation and the incidence of basal cell carcinoma and squamous cell carcinoma. The New Hampshire Skin Cancer Study Group. Arch Dermatol. 2000; 136(8):1007-11. DOI: 10.1001/archderm.136.8.1007. View

10.

Powers J, Murphy G, Ralph N, OGorman S, Murphy J . Mitochondrial DNA deletion percentage in sun exposed and non sun exposed skin. J Photochem Photobiol B. 2016; 165:277-282. DOI: 10.1016/j.jphotobiol.2016.10.030. View

11.

Villiotou V, Deliconstantinos G . Nitric oxide, peroxynitrite and nitroso-compounds formation by ultraviolet A (UVA) irradiated human squamous cell carcinoma: potential role of nitric oxide in cancer prognosis. Anticancer Res. 1995; 15(3):931-42. View

12.

Vlodavsky I, Friedmann Y . Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. J Clin Invest. 2001; 108(3):341-7. PMC: 209369. DOI: 10.1172/JCI13662. View

13.

Schwarz A, Noordegraaf M, Maeda A, Torii K, Clausen B, Schwarz T . Langerhans cells are required for UVR-induced immunosuppression. J Invest Dermatol. 2010; 130(5):1419-27. DOI: 10.1038/jid.2009.429. View

14.

Katoh Y, Katoh M . Hedgehog target genes: mechanisms of carcinogenesis induced by aberrant hedgehog signaling activation. Curr Mol Med. 2009; 9(7):873-86. DOI: 10.2174/156652409789105570. View

15.

Oro A, Higgins K . Hair cycle regulation of Hedgehog signal reception. Dev Biol. 2003; 255(2):238-48. DOI: 10.1016/s0012-1606(02)00042-8. View

16.

Guo D, Wang Q, Li C, Wang Y, Chen X . VEGF stimulated the angiogenesis by promoting the mitochondrial functions. Oncotarget. 2017; 8(44):77020-77027. PMC: 5652760. DOI: 10.18632/oncotarget.20331. View

17.

Yesantharao P, Wang W, Ioannidis N, Demehri S, Whittemore A, Asgari M . Cutaneous squamous cell cancer (cSCC) risk and the human leukocyte antigen (HLA) system. Hum Immunol. 2017; 78(4):327-335. PMC: 5428079. DOI: 10.1016/j.humimm.2017.02.002. View

18.

Wong C, Strange R, Lear J . Basal cell carcinoma. BMJ. 2003; 327(7418):794-8. PMC: 214105. DOI: 10.1136/bmj.327.7418.794. View

19.

Ruiz M, Biselli P, Maniglia J, Pavarino-Bertelli E, Goloni-Bertollo E . Genetic variability of vascular endothelial growth factor and prognosis of head and neck cancer in a Brazilian population. Braz J Med Biol Res. 2010; 43(2):127-33. DOI: 10.1590/s0100-879x2009007500036. View

20.

Harwood C, Surentheran T, McGregor J, Spink P, Leigh I, Breuer J . Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol. 2000; 61(3):289-97. DOI: 10.1002/1096-9071(200007)61:3<289::aid-jmv2>3.0.co;2-z. View